Vol 4, No 4 (August 20, 2015): Translational Lung Cancer Research (Improving the Quality and Outcomes of Lung Cancer Care: An Interdisciplinary Approach)1

Editorial

Editorial preface to this special issue “Improving the quality and outcomes of lung cancer care: an interdisciplinary approach”
Raymond U. Osarogiagbon
Translational Lung Cancer Research  
2015;
4
(4)
:322-326
.

Review Article

Global trends of lung cancer mortality and smoking prevalence
Farhad Islami, Lindsey A. Torre, Ahmedin Jemal
Translational Lung Cancer Research  
2015;
4
(4)
:327-338
.
Integration of tobacco cessation services into multidisciplinary lung cancer care: rationale, state of the art, and future directions
Graham W. Warren, Kenneth D. Ward
Translational Lung Cancer Research  
2015;
4
(4)
:339-352
.
Implementing lung cancer screening in the real world: opportunity, challenges and solutions
Robert J. Optican, Caroline Chiles
Translational Lung Cancer Research  
2015;
4
(4)
:353-364
.
What is quality, and can we define it in lung cancer?—the case for quality improvement
Farhood Farjah, Frank C. Detterbeck
Translational Lung Cancer Research  
2015;
4
(4)
:365-372
.
Measuring improvement in populations: implementing and evaluating successful change in lung cancer care
Xinhua Yu, Lisa M. Klesges, Mathew P. Smeltzer, Raymond U. Osarogiagbon
Translational Lung Cancer Research  
2015;
4
(4)
:373-384
.
Lung cancer care: the impact of facilities and area measures
Christopher S. Lathan
Translational Lung Cancer Research  
2015;
4
(4)
:385-391
.
Lung cancer diagnosis and staging in the minimally invasive age with increasing demands for tissue analysis
Erik Folch, Daniel B. Costa, Jeffrey Wright, Paul A. VanderLaan
Translational Lung Cancer Research  
2015;
4
(4)
:392-403
.
Computer modeling of lung cancer diagnosis-to-treatment process
Feng Ju, Hyo Kyung Lee, Raymond U. Osarogiagbon, Xinhua Yu, Nick Faris, Jingshan Li
Translational Lung Cancer Research  
2015;
4
(4)
:404-414
.

Perspective

Predicting the prognosis of lung cancer: the evolution of tumor, node and metastasis in the molecular age—challenges and opportunities
Ramón Rami-Porta, Hisao Asamura, Peter Goldstraw
Translational Lung Cancer Research  
2015;
4
(4)
:415-423
.
Improving lung cancer outcomes by improving the quality of surgical care
Raymond U. Osarogiagbon, Thomas A. D’Amico
Translational Lung Cancer Research  
2015;
4
(4)
:424-431
.
Improving the pathologic evaluation of lung cancer resection specimens
Raymond U. Osarogiagbon, Holly L. Hilsenbeck, Elizabeth W. Sales, Allen Berry, Robert W. Jarrett Jr, Christopher S. Giampapa, Clara N. Finch-Cruz, David Spencer
Translational Lung Cancer Research  
2015;
4
(4)
:432-437
.
Triaging early-stage lung cancer patients into non-surgical pathways: who, when, and what?
Rameses Sroufe, Feng-Ming (Spring) Kong
Translational Lung Cancer Research  
2015;
4
(4)
:438-447
.
Implementing effective and sustainable multidisciplinary clinical thoracic oncology programs
Raymond U. Osarogiagbon, Richard K. Freeman, Mark J. Krasna
Translational Lung Cancer Research  
2015;
4
(4)
:448-455
.

Original Article

‘One-stop shop’: lung cancer patients’ and caregivers’ perceptions of multidisciplinary care in a community healthcare setting
Satish K. Kedia, Kenneth D. Ward, Siri A. Digney, Bianca M. Jackson, April L. Nellum, Laura McHugh, Kristina S. Roark, Orion T. Osborne, Fayre J. Crossley, Nicholas Faris, Raymond U. Osarogiagbon
Translational Lung Cancer Research  
2015;
4
(4)
:456-464
.
Erlotinib therapy after initial platinum doublet therapy in patients with EGFR wild type non-small cell lung cancer: results of a combined patient-level analysis of the NCIC CTG BR.21 and SATURN trials
Raymond U. Osarogiagbon, Federico Cappuzzo, Tudor Ciuleanu, Larry Leon, Barbara Klughammer
Translational Lung Cancer Research  
2015;
4
(4)
:465-474
.

Controversies on Lung Cancer: Pros and Cons (Section Chairs: Suresh Senan, Helmut H. Popper)2

Exploring controversies in lung cancer using structured pro-con debates
Suresh Senan
Translational Lung Cancer Research  
2015;
4
(4)
:475
.
Pros: long-term CT scan follow-up should be the standard of care in patients who are curatively treated for an early-stage non-small cell lung cancer
Waël C. Hanna
Translational Lung Cancer Research  
2015;
4
(4)
:476-478
.
Cons: long-term CT-scan follow-up is not the standard of care in patients curatively treated for an early stage non-small cell lung cancer
Jan P. van Meerbeeck, Halil Sirimsi
Translational Lung Cancer Research  
2015;
4
(4)
:479-483
.
Rebuttal from Dr Hanna
Waël C. Hanna
Translational Lung Cancer Research  
2015;
4
(4)
:484
.
Rebuttal from Dr van Meerbeeck
Jan P. van Meerbeeck
Translational Lung Cancer Research  
2015;
4
(4)
:485-486
.

Evidence-Based Medicine3

A meta-analysis of safety and efficacy on first-line S-1 therapy in cancer patients
Yingying Miao, Ping Zhan, Tangfeng Lv, Yong Song
Translational Lung Cancer Research  
2015;
4
(4)
:487-497
.

Meet the Professor4

Professor Caicun Zhou: a successful step forward for international exchange on combating lung cancer
Melanie C. He
Translational Lung Cancer Research  
2015;
4
(4)
:498-500
.

Disclosure:

1. The focused issue “Improving the Quality and Outcomes of Lung Cancer Care: An Interdisciplinary Approach” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Raymond U. Osarogiagbon served as the unpaid Guest Editor for the focused issue.

2. The series “Controversies on Lung Cancer: Pros and Cons” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding. Suresh Senan and Helmut H. Popper served as the unpaid Guest Editors for the series.

3. The series “Evidence-Based Medicine” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding.

4. The series “Meet the Professor” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding.